Carnoy's solution increases the number of examined lymph nodes following gastrectomy for adenocarcinoma: a randomized trial

Show simple item record

dc.contributor Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.author DIAS, Andre Roncon FMUSP-HC
PEREIRA, Marina Alessandra FMUSP-HC
MELLO, Evandro Sobroza FMUSP-HC
ZILBERSTEIN, Bruno FMUSP-HC
CECCONELLO, Ivan FMUSP-HC
RIBEIRO JUNIOR, Ulysses FMUSP-HC
dc.date.issued 2016
dc.identifier.citation GASTRIC CANCER, v.19, n.1, p.136-142, 2016
dc.identifier.issn 1436-3291
dc.identifier.uri http://observatorio.fm.usp.br/handle/OPI/13520
dc.description.abstract Pathological examination of a minimum of 16 lymph nodes is recommended following surgery for gastric adenocarcinoma, despite this a longer survival is expected when 30 or more lymph nodes are examined. Small lymph nodes are difficult to identify, and fat-clearing solutions have been proposed to improve this, but there is no evidence of their clinical benefit. Fifty D2 subtotal gastrectomy specimens were randomized for fixation in Carnoy's solution (CS) or 10 % neutral buffered formalin (NBF), with subsequent fat dissection. After dissection, the residual fat from the NBF group, instead of being discarded, was immersed in CS and dissected again. Data from 25 D2 subtotal gastrectomies performed before the study were also analyzed. The mean number of examined lymph nodes was 50.4 and 34.8 for CS and NBF, respectively (p < 0.001). Missing lymph nodes were found in all cases from the residual fat group (mean of 16.9), and in eight of them (32 %) metastatic lymph nodes were present; this allowed the upstaging of two patients. Lymph nodes in the CS group were smaller than those in the NBF group (p = 0.01). The number of retrieved lymph nodes was similar among the NBF and Retrospective groups (p = 0.802). Compared with NBF, CS increases lymph node detection following gastrectomy and allows a more accurate pathological staging. No influence of the research protocol on the number of examined lymph nodes was observed.
dc.language.iso eng
dc.publisher SPRINGER
dc.relation.ispartof Gastric Cancer
dc.rights restrictedAccess
dc.subject Stomach neoplasms; Lymph node excision; Carnoy's solution; Lymph node revealing solution; Random allocation; Pathology
dc.subject.other negative gastric-cancer; international-union; tnm classification; revealing solution; 7th edition; carcinoma; micrometastasis
dc.title Carnoy's solution increases the number of examined lymph nodes following gastrectomy for adenocarcinoma: a randomized trial
dc.type article
dc.rights.holder Copyright SPRINGER
dc.description.group LIM/14
dc.description.group LIM/35
dc.description.group LIM/37
dc.identifier.doi 10.1007/s10120-014-0443-2
dc.identifier.pmid 25410474
dc.type.category original article
dc.type.version publishedVersion
hcfmusp.author DIAS, Andre Roncon:HC:ICESP
hcfmusp.author PEREIRA, Marina Alessandra:HC:ICESP
hcfmusp.author MELLO, Evandro Sobroza:FM:MPT
hcfmusp.author ZILBERSTEIN, Bruno:FM:MGT
hcfmusp.author CECCONELLO, Ivan:FM:MGT
hcfmusp.author RIBEIRO JUNIOR, Ulysses:FM:MGT
hcfmusp.origem.id WOS:000367260300017
hcfmusp.origem.id 2-s2.0-84951567522
hcfmusp.publisher.city NEW YORK
hcfmusp.publisher.country USA
hcfmusp.relation.reference · Agency for Toxic Substances and Disease Registry (US), 1997, TOX PROF CHLOR
· Agency for Toxic Substances and Disease Registry (US), 1999, TOX PROF FORM
· American Conference of Governmental Industrial Hygienists, 2001, THRESH LIM VAL TIVS
· Bunt AMG, 1996, J CLIN ONCOL, V14, P2289
· Nashimoto A, 2013, GASTRIC CANCER, V16, P1, DOI 10.1007/s10120-012-0163-4
· Baiocchi GL, 2010, ANN SURG, V252, P70, DOI 10.1097/SLA.0b013e3181e4585e
· Ishigami S, 2003, AM SURGEON, V69, P573
· WAGNER PK, 1991, BRIT J SURG, V78, P825, DOI 10.1002/bjs.1800780719
· Compton C, 1998, ARCH PATHOL LAB MED, V122, P9
· Marrelli D, 2012, ANN SURG, V255, P486, DOI 10.1097/SLA.0b013e3182389b1a
· Ichikura T, 2003, WORLD J SURG, V27, P330, DOI 10.1007/s00268-002-6730-9
· Yasuda K, 2002, ANN SURG ONCOL, V9, P771, DOI 10.1245/ASO.2002.01.001
· Luz DABP, 2008, HISTOPATHOLOGY, V53, P740, DOI 10.1111/j.1365-2559.2008.03148.x
· Koren R, 1998, ONCOL REP, V5, P341
· CANDELA FC, 1990, CANCER, V66, P1828, DOI 10.1002/1097-0142(19901015)66:8<1828::AID-CNCR2820660830>3.0.CO;2-Z
· Roth AD, 2003, CRIT REV ONCOL HEMAT, V46, P59, DOI 10.1016/S1040-8428(02)00160-9
· Abbassi-Ghadi N, 2012, HISTOPATHOLOGY, V61, P531, DOI 10.1111/j.1365-2559.2012.04357.x
· Seevaratnam R, 2012, GASTRIC CANCER, V15, pS70, DOI 10.1007/s10120-012-0169-y
· Noda N, 1998, BRIT J SURG, V85, P831
· Huang CM, 2011, GASTROENT RES PRACT, DOI 10.1155/2011/476014
· Wu ZY, 2007, WORLD J GASTROENTERO, V13, P4122
· Reim D, 2013, J CLIN ONCOL, V31, P263, DOI 10.1200/JCO.2012.44.4315
· Luebke T, 2005, ONCOL REP, V13, P361
· Kikuchi S, 2011, ANTICANCER RES, V31, P2361
· Fang WL, 2011, WORLD J SURG, V35, P2723, DOI 10.1007/s00268-011-1275-4
· Association JGC, 2011, GASTRIC CANCER, V14, P113
· Cecconello I, 2012, ABCD-ARQ BRAS CIR DI, V25, P161
· Chen K, 2013, WORLD J SURG ONCOL, V8, P182
· Dell'Aquila Jr Nelson Fausto, 2008, ABCD, arq. bras. cir. dig., V21, P164, DOI 10.1590/S0102-67202008000400003
· Kesley R, 2005, APPL CANC RES, V25, P122
· Pereira MA, 2015, HISTOPATHOLOGY, V66, P388, DOI 10.1111/his.12532
· Siqueira PR, 2000, REV COL BRAS CIR, V27, P221
· Xu DZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038681
dc.description.index MEDLINE
dc.identifier.eissn 1436-3305
hcfmusp.citation.scopus 21


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace



Browse

My Account

Statistics